KRAS mutation status, comorbidity, and mortality in patients with metastatic colorectal cancer in Denmark

Authors

  • Anne Gulbech Ording Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
  • Buket Öztürk Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
  • Karen-Lise Garm Spindler Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark; ;Department of Oncology, Aarhus University Hospital, Aarhus, Denmark
  • Henrik Toft Sørensen Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
  • Margaret McCusker Diagnostics Information Solutions, F Hoffmann-La Roche AG, Pleasanton, CA, USA
  • Vera Ehrenstein Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark

DOI:

https://doi.org/10.1080/0284186X.2018.1503420

Abstract

No Abstract Available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2018-12-02

How to Cite

Gulbech Ording, A. ., Öztürk, B. ., Garm Spindler, K.-L. ., Toft Sørensen, H. ., McCusker, M. ., & Ehrenstein, V. . (2018). KRAS mutation status, comorbidity, and mortality in patients with metastatic colorectal cancer in Denmark. Acta Oncologica, 57(12), 1727–1729. https://doi.org/10.1080/0284186X.2018.1503420

Issue

Vol. 57 No. 12 (2018): Acta Oncologica

Section

Articles